These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4934423)

  • 1. Karyotypic and surface features of murine TA3 carcinoma cells during immunoselection in mice and rats.
    Hauschka TS; Weiss L; Holdridge BA; Cudney TL; Zumpft M; Planinsek JA
    J Natl Cancer Inst; 1971 Aug; 47(2):343-59. PubMed ID: 4934423
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic control of spontaneous resistance to murine adenocarcinoma (ADK-lt)].
    Serrati G; Giordano L; Giovarelli M; Forni G
    G Batteriol Virol Immunol; 1979; 72(1-6):115-26. PubMed ID: 553836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic enhancement by neuraminidase.
    Oxley S; Griffen WO
    Surg Forum; 1971; 22():113-4. PubMed ID: 5121313
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 8. Two kinds of antigen suppression in tumor cells revealed by cell fusion.
    Klein G; Friberg S; Harris H
    J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.
    Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW
    Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. II. Search for a common antigen in some organs and spontaneous mammary carcinomas.
    Rejthar A; Wotke J
    Folia Biol (Krakow); 1973; 21(1):52-7. PubMed ID: 4693119
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
    Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
    J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
    Miller SC; Codington JF; Klein G
    J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alteration in tumor histocompatibility induced by neuraminidase.
    Sanford BH
    Transplantation; 1967 Sep; 5(5):1273-9. PubMed ID: 6056941
    [No Abstract]   [Full Text] [Related]  

  • 14. Cycling of immune responses to a syngeneic murine mammary adenocarcinoma.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3484-90. PubMed ID: 6449282
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
    Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
    Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57BL/6 mice: participation of neutrophils and activated macrophages with fibrin formation.
    Dvorak AM; Connell AB; Proppe K; Dvorak HF
    J Immunol; 1978 Apr; 120(4):1240-8. PubMed ID: 641347
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibody against a cryptic carbohydrate antigen of murine and human lymphocytes. I. Antigen expression in non-cryptic or unsubstituted form on certain murine lymphomas, on a spontaneous murine mammary carcinoma, and on several human adenocarcinomas.
    Longenecker BM; Rahman AF; Leigh JB; Purser RA; Greenberg AH; Willans DJ; Keller O; Petrik PK; Thay TY; Suresh MR
    Int J Cancer; 1984 Jan; 33(1):123-9. PubMed ID: 6198295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors.
    Irie RF; Koyama K; Hino S
    J Natl Cancer Inst; 1970 Sep; 45(3):515-24. PubMed ID: 5523194
    [No Abstract]   [Full Text] [Related]  

  • 20. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB
    J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.